Cargando…

Psychoactive substances as a last resort—a qualitative study of self-treatment of migraine and cluster headaches

BACKGROUND: Treatment resistant cluster headache and migraine patients are exploring alternative treatments online. The aim of this study was to improve comprehension regarding the use of non-established or alternative pharmacological treatments used by sufferers of cluster headaches and migraines....

Descripción completa

Detalles Bibliográficos
Autores principales:	Andersson, Martin, Persson, Mari, Kjellgren, Anette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584001/ https://www.ncbi.nlm.nih.gov/pubmed/28870224 http://dx.doi.org/10.1186/s12954-017-0186-6

Ejemplares similares

The slippery slope of flubromazolam: Experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum
por: Andersson, Martin, et al.
Publicado: (2017)

Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube
por: Andersson, Martin, et al.
Publicado: (2019)

Safe doubling of ventilator capacity: a last resort proposal for last resorts
por: Chase, J. Geoffrey, et al.
Publicado: (2020)

Debt Relief as a Last Resort for the Lender of Last Resort?: Monetary Financing — Doing It Right
por: Hansen, Arne, et al.
Publicado: (2021)

Commentary: The time for last-resort measures—be prepared
por: Martin, Elisabeth, et al.
Publicado: (2020)

Last resort: psychosurgery and the limits of medicine
por: Brown, Edward M
Publicado: (1999)

Debate: Are cluster headache and migraine distinct headache disorders?
por: Al-Karagholi, Mohammad Al-Mahdi, et al.
Publicado: (2022)

The borderline between cluster headache and migraine: does cluster-migraine exist?
por: Lisotto, C, et al.
Publicado: (2013)

Surgery for Crohn’s disease: upfront or last resort?
por: Ahmed Ali, U, et al.
Publicado: (2022)

Migraine and cluster headache – the common link
por: Vollesen, Anne Luise, et al.
Publicado: (2018)

ANALYTICALLY CONFIRMED PRESENCE OF PSYCHOACTIVE SUBSTANCES, ESPECIALLY NEW PSYCHOACTIVE SUBSTANCES IN A GROUP OF PATIENTS HOSPITALIZED WITH MENTAL AND BEHAVIOURAL DISORDERS DUE TO THE USE OF PSYCHOACTIVE SUBSTANCES DIAGNOSIS
por: Engelgardt, Piotr, et al.
Publicado: (2022)

In-Patient Treatment: Should It Become a Last Resort?
por: Bosanquet, Marion F.
Publicado: (1963)

Acute pharmacotherapy of migraine, tension-type headache, and cluster headache
por: Tfelt-Hansen, Peer
Publicado: (2007)

Oxygen Therapy in Cluster Headache, Migraine, and Other Headache Disorders
por: Mo, Heejung, et al.
Publicado: (2022)

In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters
por: Botha, Michelle J., et al.
Publicado: (2022)

Fifteen Years of India’s NREGA: Employer of the Last Resort?
por: Narayan, Swati
Publicado: (2022)

The last resort: Workplace bullying and the consequences of changing jobs
por: Rosander, Michael, et al.
Publicado: (2022)

Novel Psychoactive Substances and Behavioral Addictions
por: Martinotti, Giovanni, et al.
Publicado: (2014)

Editorial: Pharmacology of new psychoactive substances
por: Lutfy, K., et al.
Publicado: (2023)

The utility of recombinant factor VIIa as a last resort in trauma
por: Mamtani, Rishi, et al.
Publicado: (2012)

Banning Psychoactive Substances: A Slippery Slope
Publicado: (2015)

New Psychoactive Substances: A Matter of Time
por: Pantano, Flaminia, et al.
Publicado: (2019)

New psychoactive substances: a review and updates
por: Shafi, Abu, et al.
Publicado: (2020)

Polymyxin and lipopeptide antibiotics: membrane-targeting drugs of last resort
por: Ledger, Elizabeth V. K., et al.
Publicado: (2022)

Raman-Based Antimicrobial Susceptibility Testing on Antibiotics of Last Resort
por: Xiao, Zhirou, et al.
Publicado: (2023)

Novel Psychoactive Substances: The Razor’s Edge between Therapeutical Potential and Psychoactive Recreational Misuse
por: Correia, Beatriz, et al.
Publicado: (2022)

A qualitative study to understand drivers of psychoactive substance use among Nepalese youth
por: Bhandari, Tulsi Ram, et al.
Publicado: (2021)

Suicidality and self-injury behaviours due to the use of Novel Psychoactive Substances (NPS)
por: Orsolini, L.
Publicado: (2023)

Phenytoin as a last‐resort treatment in SCN8A encephalopathy
por: Braakman, Hilde M., et al.
Publicado: (2017)

Current Understanding on Pain Mechanism in Migraine and Cluster Headache
por: Buture, Alina, et al.
Publicado: (2016)

Migraine and cluster headache show impaired neurosteroids patterns
por: Koverech, Angela, et al.
Publicado: (2019)

Psychoactive substances and the political ecology of mental distress
por: Aggarwal, Sunil K, et al.
Publicado: (2012)

PSYCHOACTIVE SUBSTANCE USE AMONG MEDICAL STUDENTS
por: Ali, R.V. Zulfikar, et al.
Publicado: (1994)

Priapism associated with novel psychoactive substance abuse
por: Jones, Patrick, et al.
Publicado: (2015)

An Expanding World of Novel Psychoactive Substances: Opioids
por: Zawilska, Jolanta B.
Publicado: (2017)

Experimentation with psychoactive substances by public school students
por: de Andrade, Maria Eliane, et al.
Publicado: (2017)

Psychoactive Substances Taken with Mephedrone and HCV Infection
por: Ordak, Michal, et al.
Publicado: (2021)

Molecular Insights on New Psychoactive Substances (NPSs)
por: Busardò, Francesco Paolo, et al.
Publicado: (2022)

An Update on Psychoactive Substances: Pharmacology and Toxicology Issues
por: Chiappini, Stefania, et al.
Publicado: (2023)

Genotoxicity Evaluation of The Novel Psychoactive Substance MTTA
por: Lenzi, Monia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_svisr10gbf8srbdqbkhunv64dj